» Articles » PMID: 33937263

Heterozygous Recurrent Mutations Inducing Dysfunction of Gene in Patients With Short Stature

Abstract

Purpose: ROR2, a member of the ROR family, is essential for skeletal development as a receptor of Wnt5a. The present study aims to investigate the mutational spectrum of in children with short stature and to identify the underlying molecular mechanisms.

Methods: We retrospectively analyzed clinical phenotype and whole-exome sequencing (WES) data of 426 patients with short stature through mutation screening of . We subsequently examined the changes in protein expression and subcellular location in caused by the mutations. The mRNA expression of downstream signaling molecules of the Wnt5a-ROR2 pathway was also examined.

Results: We identified 12 mutations in in 21 patients, including 10 missense, one nonsense, and one frameshift. Among all missense variants, four recurrent missense variants [c.1675G > A(p.Gly559Ser), c.2212C > T(p.Arg738Cys), c.1930G > A(p.Asp644Asn), c.2117G > A(p.Arg706Gln)] were analyzed by experiments . The c.1675G > A mutation significantly altered the expression and the cellular localization of the ROR2 protein. The c.1675G > A mutation also caused a significantly decreased expression of c-Jun. In contrast, other missense variants did not confer any disruptive effect on the biological functions of ROR2.

Conclusion: We expanded the mutational spectrum of in patients with short stature. Functional experiments potentially revealed a novel molecular mechanism that the c.1675G > A mutation in might affect the expression of downstream Wnt5a-ROR2 pathway gene by disturbing the subcellular localization and expression of the protein.

Citing Articles

Therapeutic advances of targeting receptor tyrosine kinases in cancer.

Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A Signal Transduct Target Ther. 2024; 9(1):201.

PMID: 39138146 PMC: 11323831. DOI: 10.1038/s41392-024-01899-w.


Successful therapeutic intervention in new mouse models of frizzled 2-associated congenital malformations.

Liegel R, Michalski M, Vaidya S, Bittermann E, Finnerty E, Menke C Development. 2023; 150(3).

PMID: 36789910 PMC: 10112907. DOI: 10.1242/dev.201038.


Novel Candidate Genes for Non-Syndromic Tooth Agenesis Identified Using Targeted Next-Generation Sequencing.

Biedziak B, Firlej E, Dabrowska J, Bogdanowicz A, Zadurska M, Mostowska A J Clin Med. 2022; 11(20).

PMID: 36294409 PMC: 9605476. DOI: 10.3390/jcm11206089.


Serum Metabonomics Reveals Key Metabolites in Different Types of Childhood Short Stature.

Chen G, Wang J, Jing Y, Li C, Zhang W, Yang S Front Pharmacol. 2022; 13:818952.

PMID: 35600884 PMC: 9117746. DOI: 10.3389/fphar.2022.818952.


Whole Exome Sequencing Uncovered the Genetic Architecture of Growth Hormone Deficiency Patients.

Yu C, Xie B, Zhao Z, Zhao S, Liu L, Cheng X Front Endocrinol (Lausanne). 2021; 12:711991.

PMID: 34589056 PMC: 8475633. DOI: 10.3389/fendo.2021.711991.

References
1.
Fan X, Zhao S, Yu C, Wu D, Yan Z, Fan L . Exome sequencing reveals genetic architecture in patients with isolated or syndromic short stature. J Genet Genomics. 2021; 48(5):396-402. DOI: 10.1016/j.jgg.2021.02.008. View

2.
Yamamoto H, Yoo S, Nishita M, Kikuchi A, Minami Y . Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells. 2007; 12(11):1215-23. DOI: 10.1111/j.1365-2443.2007.01128.x. View

3.
Maeda K, Kobayashi Y, Udagawa N, Uehara S, Ishihara A, Mizoguchi T . Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med. 2012; 18(3):405-12. DOI: 10.1038/nm.2653. View

4.
Huang J, Shi Y, Li H, Tan D, Yang M, Wu X . Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression. Oncol Lett. 2016; 10(6):3705-3711. PMC: 4665612. DOI: 10.3892/ol.2015.3797. View

5.
Kirat E, Albayrak H, Sahinoglu B, Gurler A, Karaer K . Autosomal recessive Robinow syndrome with novel ROR2 variants: distinct cases exhibiting the clinical variability. Clin Dysmorphol. 2020; 29(3):137-140. DOI: 10.1097/MCD.0000000000000319. View